C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men

Author： Laaksonen D. Niskanen L. Nyyssönen K. Punnonen K. Tuomainen T.-P. Valkonen V.-P. Salonen R. Salonen J.

ISSN： 0012-186X

Source： Diabetologia, Vol.47, Iss.8, 2004-08, pp. : 1403-1410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study

By Satar N. Gaw A. Scherbakova O.

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 26-26

Elsevier

Access to resources Recommend Favorite

Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT): A Prospective-Randomized Study in Middle Aged Men and Women

Current Vascular Pharmacology, Vol. 9, Iss. 6, 2011-11 ,pp. : 647-657

Bentham Science Publishers

Access to resources Recommend Favorite

Differences in the pathology of the metabolic syndrome with or without visceral fat accumulation: A study in pre-diabetic Japanese middle-aged men

By Mori Yutaka Hoshino Kyouko Yokota Kuninobu Itoh Yohta Tajima Naoko

Endocrine Journal, Vol. 29, Iss. 1, 2006-02 ,pp. : 149-153

Humana Press, Inc

Access to resources Recommend Favorite

Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome

By Wang T.-D. Chen W.-J. Lin J.-W. Chen M.-F. Lee Y.-T.

The American Journal of Cardiology, Vol. 93, Iss. 3, 2004-02 ,pp. : 362-365

Elsevier

Access to resources Recommend Favorite

Serum C-reactive protein and metabolic components

By Kawada Tomoyuki

Endocrine, Vol. 44, Iss. 3, 2013-12 ,pp. : 819-819

Springer Publishing Company

Access to resources Recommend Favorite